On February 28, 2024 Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, reported that management will participate in the following upcoming investor conferences (Press release, Alector, FEB 28, 2024, View Source [SID1234640571]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

TD Cowen 44th Annual Health Care Conference (Boston, Massachusetts)
Tuesday, March 5, 2024, at 10:30 a.m. ET, panel
Leerink Partners Global Biopharma Conference (Miami, Florida)
Tuesday, March 12, 2024, at 10:40 a.m. ET, corporate presentation
Barclays 26th Annual Global Healthcare Conference (Miami, Florida)
Wednesday, March 13, 2024, at 2:05 p.m. ET, fireside chat
Stifel 2024 CNS Days (Virtual)
Tuesday, March 19, 2024, at 11:30 a.m. ET, fireside chat
A webcast of each conference presentation will be available on the "Events & Presentations" page within the Investors section of the Alector website at View Source Replays of the webcasts will be available on the Alector website for 90 days following the presentation dates.